WEBULL

Assessing Enterprise Products Partners (EPD) Valuation After $300 Million Debt Raise and Growth Plans

Simply Wall St · 11/15/2025 17:22

Enterprise Products Partners (EPD) recently completed a substantial fixed-income offering, raising over $300 million through senior unsecured notes at a 4.3% coupon. This move highlights the company's ongoing approach to managing its capital structure and funding strategy.

See our latest analysis for Enterprise Products Partners.

Enterprise Products Partners' recent completion of its fixed-income offering follows its participation at the Bank of America Global Energy Conference, reflecting increased market interest in the company. The share price has climbed 5.77% over the past month, with positive momentum building after the announcement. Long-term investors have enjoyed a robust 11.09% total shareholder return over the past year. The combination of steady share price gains and consistent total returns suggests that sentiment around the company's growth outlook is improving as capital structure initiatives unfold.

If you're looking to expand your search beyond familiar names, now is a great moment to discover fast growing stocks with high insider ownership.

With shares up strongly this year but still trading below some analyst targets, the key question now is whether Enterprise Products Partners remains undervalued or if the market has already anticipated its next phase of growth.

Most Popular Narrative: 10.1% Undervalued

Enterprise Products Partners currently trades at $32.26, compared to the narrative fair value of $35.89. The latest consensus narrative sees near-term upside given the company’s operational improvements and growth projects.

The completion of two gas processing plants in the Permian, along with several key pipeline and export terminal projects, is expected to enhance Enterprise Products Partners’ infrastructure. This could drive revenue growth from increased volume handling and exports. With no major planned downtimes for the PDH plants after recent maintenance, Enterprise is positioned to capture additional EBITDA that was previously lost to unplanned outages. This suggests potential earnings improvement.

Read the complete narrative.

Want to know what’s fueling this outlook? The narrative’s valuation leans on ambitious earnings and margin gains, with future profit multiples that may surprise even market veterans. Do the math for yourself; the real story is in the bold forecasts behind that fair value.

Result: Fair Value of $35.89 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, operational hiccups or unfavorable changes in export tariffs could quickly dampen the upside projected in this analyst narrative.

Find out about the key risks to this Enterprise Products Partners narrative.

Build Your Own Enterprise Products Partners Narrative

If you have your own perspective or prefer to dig into the numbers firsthand, you can build a personalized narrative in just a few minutes. Do it your way.

A great starting point for your Enterprise Products Partners research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Ready for More Investment Ideas?

If you only focus on today’s winners, you might miss the next breakout stock. Let the Simply Wall Street Screener uncover tomorrow’s opportunity for you.

  • Supercharge your portfolio by targeting steady income streams with these 16 dividend stocks with yields > 3%, offering yields above 3% and reliable fundamentals.
  • Gain an edge in the healthcare revolution by checking out these 31 healthcare AI stocks, which is powering breakthroughs in medical technology and artificial intelligence.
  • Jump ahead of the curve and catch trends early through these 25 AI penny stocks, where innovative companies are driving growth in AI-powered sectors.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.